HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology
dc.creator | Barone E. | |
dc.creator | Head E. | |
dc.creator | Butterfield D.A. | |
dc.creator | Perluigi M. | |
dc.date.accessioned | 2020-09-02T22:12:59Z | |
dc.date.accessioned | 2022-11-08T20:24:31Z | |
dc.date.available | 2020-09-02T22:12:59Z | |
dc.date.available | 2022-11-08T20:24:31Z | |
dc.date.created | 2020-09-02T22:12:59Z | |
dc.date.issued | 2017 | |
dc.identifier | 111, , 262-269 | |
dc.identifier | 08915849 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3683 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145295 | |
dc.language | en | |
dc.publisher | Elsevier Inc. | |
dc.subject | 4-hydroxy-2-nonenal | |
dc.subject | Alzheimer disease | |
dc.subject | Down syndrome | |
dc.subject | Lipid peroxidation | |
dc.subject | Protein oxidation | |
dc.subject | Redox proteomics | |
dc.subject | 4 hydroxynonenal | |
dc.subject | glucose | |
dc.subject | protein | |
dc.subject | 4-hydroxy-2-nonenal | |
dc.subject | aldehyde | |
dc.subject | amyloid beta protein | |
dc.subject | glucose | |
dc.subject | MAPT protein, human | |
dc.subject | tau protein | |
dc.subject | Alzheimer disease | |
dc.subject | Down syndrome | |
dc.subject | glucose metabolism | |
dc.subject | human | |
dc.subject | lipid peroxidation | |
dc.subject | molecular pathology | |
dc.subject | nerve degeneration | |
dc.subject | neuropathology | |
dc.subject | nonhuman | |
dc.subject | oxidation reduction reaction | |
dc.subject | oxidative stress | |
dc.subject | priority journal | |
dc.subject | protein modification | |
dc.subject | protein processing | |
dc.subject | protein quality | |
dc.subject | proteomics | |
dc.subject | Review | |
dc.subject | Alzheimer disease | |
dc.subject | amyloid plaque | |
dc.subject | Down syndrome | |
dc.subject | genetics | |
dc.subject | lipid peroxidation | |
dc.subject | metabolism | |
dc.subject | mitochondrion | |
dc.subject | nerve cell | |
dc.subject | neurofibrillary tangle | |
dc.subject | oxidative stress | |
dc.subject | pathology | |
dc.subject | protein processing | |
dc.subject | Aldehydes | |
dc.subject | Alzheimer Disease | |
dc.subject | Amyloid beta-Peptides | |
dc.subject | Down Syndrome | |
dc.subject | Glucose | |
dc.subject | Humans | |
dc.subject | Lipid Peroxidation | |
dc.subject | Mitochondria | |
dc.subject | Neurofibrillary Tangles | |
dc.subject | Neurons | |
dc.subject | Oxidative Stress | |
dc.subject | Plaque, Amyloid | |
dc.subject | Protein Processing, Post-Translational | |
dc.subject | tau Proteins | |
dc.title | HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology | |
dc.type | Review |